Shanghai Rendu Biotechnology Co. Ltd. A (688193) - Total Liabilities

Latest as of March 2026: CN¥65.45 Million CNY ≈ $9.58 Million USD

Based on the latest financial reports, Shanghai Rendu Biotechnology Co. Ltd. A (688193) has total liabilities worth CN¥65.45 Million CNY (≈ $9.58 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 688193 year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Shanghai Rendu Biotechnology Co. Ltd. A - Total Liabilities Trend (2019–2025)

This chart illustrates how Shanghai Rendu Biotechnology Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. See 688193 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Shanghai Rendu Biotechnology Co. Ltd. A Competitors by Total Liabilities

The table below lists competitors of Shanghai Rendu Biotechnology Co. Ltd. A ranked by their total liabilities.

Company	Country	Total Liabilities
Rexon Industrial Corp Ltd TW:1515	Taiwan	NT$3.66 Billion
G1 Secure Solutions Ltd TA:GOSS	Israel	ILA367.26 Million
Zhejiang Dilong New Material Co Ltd SHE:002247	China	CN¥281.35 Million
American Realty Investors Inc NYSE:ARL	USA	$287.64 Million
Shenzhen Maxonic Auto Control SHE:300112	China	CN¥580.21 Million
Batavia Prosperindo Int JK:BPII	Indonesia	Rp3.40 Trillion
Seneca Foods Corp B NASDAQ:SENEB	USA	$508.64 Million
Ginwa Enterprise Group Inc SHG:600080	China	CN¥370.80 Million

Liability Composition Analysis (2019–2025)

This chart breaks down Shanghai Rendu Biotechnology Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688193 market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	14.97	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.07	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.07	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shanghai Rendu Biotechnology Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shanghai Rendu Biotechnology Co. Ltd. A (2019–2025)

The table below shows the annual total liabilities of Shanghai Rendu Biotechnology Co. Ltd. A from 2019 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥76.26 Million ≈ $11.16 Million	-7.54%
2024-12-31	CN¥82.48 Million ≈ $12.07 Million	-10.32%
2023-12-31	CN¥91.97 Million ≈ $13.46 Million	-27.77%
2022-12-31	CN¥127.34 Million ≈ $18.63 Million	+40.15%
2021-12-31	CN¥90.86 Million ≈ $13.30 Million	-5.11%
2020-12-31	CN¥95.75 Million ≈ $14.01 Million	+163.00%
2019-12-31	CN¥36.41 Million ≈ $5.33 Million	--

About Shanghai Rendu Biotechnology Co. Ltd. A

SHG:688193 China Diagnostics & Research

Market Cap

$251.48 Million

CN¥1.72 Billion CNY

Market Cap Rank

#15528 Global

#4482 in China

Share Price

CN¥42.89

Change (1 day)

-3.03%

52-Week Range

CN¥42.89 - CN¥61.67

All Time High

CN¥63.91